China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) announced a 1-for-80 share consolidation of its Class A and Class B ordinary shares, effective August 10, 2026, according to a press release from the Taizhou, China-based company.

Prior to the consolidation, 105,704,077 Class A ordinary shares are issued and outstanding. Following the consolidation, approximately 1,321,301 Class A ordinary shares will be outstanding, with every 80 shares combined into one share. Fractional shares will be rounded up to the next whole share.

The company's Class A ordinary shares will continue trading on the Nasdaq Stock Market under the ticker symbol "SXTC" on a post-consolidation basis beginning at market open on August 10, 2026, under the new CUSIP number G2161P173.

All outstanding stock options, warrants, and other rights to purchase Class A ordinary shares will be adjusted proportionately as a result of the consolidation. Shareholders holding shares through a bank, broker, or other nominee will have their shares automatically adjusted to reflect the change.